Mohamed Hatmi

1.2k total citations
39 papers, 978 citations indexed

About

Mohamed Hatmi is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Internal Medicine. According to data from OpenAlex, Mohamed Hatmi has authored 39 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 16 papers in Hematology and 10 papers in Internal Medicine. Recurrent topics in Mohamed Hatmi's work include Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Platelet Disorders and Treatments (9 papers). Mohamed Hatmi is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Platelet Disorders and Treatments (9 papers). Mohamed Hatmi collaborates with scholars based in France, Tunisia and United States. Mohamed Hatmi's co-authors include Ismaı̈l Elalamy, Grigoris Gerotziafas, M Samama, Ahmad Faili, Tahar Chakroun, Cassian Bon, Geneviève Nguyen, Jean–Daniel Sraer, Françoise Robert and Claude Jacquemin and has published in prestigious journals such as Journal of Biological Chemistry, Blood and European Journal of Biochemistry.

In The Last Decade

Mohamed Hatmi

38 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohamed Hatmi France	18	330	315	231	168	148	39	978
Michael Tencati United States	14	517 1.6×	377 1.2×	197 0.9×	111 0.7×	133 0.9×	17	1.5k
А. В. Мазуров Russia	19	514 1.6×	279 0.9×	219 0.9×	85 0.5×	66 0.4×	80	1.1k
Takayuki Iwaki Japan	18	315 1.0×	202 0.6×	161 0.7×	66 0.4×	105 0.7×	44	1.1k
J. Vermylen Belgium	18	336 1.0×	144 0.5×	183 0.8×	102 0.6×	175 1.2×	59	983
Henri Roger Lijnen Belgium	18	292 0.9×	288 0.9×	159 0.7×	77 0.5×	366 2.5×	37	1.2k
Chandrashekhara Manithody United States	22	804 2.4×	288 0.9×	157 0.7×	73 0.4×	221 1.5×	61	1.3k
Fladia Phoenix United Kingdom	15	179 0.5×	231 0.7×	199 0.9×	104 0.6×	46 0.3×	26	895
Brian Estevez United States	10	305 0.9×	212 0.7×	165 0.7×	53 0.3×	53 0.4×	13	782
M R Elstad United States	10	404 1.2×	238 0.8×	198 0.9×	27 0.2×	123 0.8×	10	1.2k
Junjie Kou China	21	199 0.6×	587 1.9×	112 0.5×	97 0.6×	127 0.9×	44	1.1k

Countries citing papers authored by Mohamed Hatmi

Since Specialization

Citations

This map shows the geographic impact of Mohamed Hatmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Hatmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Hatmi more than expected).

Fields of papers citing papers by Mohamed Hatmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Hatmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Hatmi. The network helps show where Mohamed Hatmi may publish in the future.

Co-authorship network of co-authors of Mohamed Hatmi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Hatmi. A scholar is included among the top collaborators of Mohamed Hatmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Hatmi. Mohamed Hatmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gerotziafas, Grigoris, Elisabeth Mbemba, Patrick Van Dreden, et al.. (2014). Effect of Low Molecular Weight Heparins and Fondaparinux Upon Thrombin Generation Triggered by Human Pancreatic Cancer Cells BXPC3. Current Vascular Pharmacology. 12(6). 893–902. 11 indexed citations

Rousseau, Aurélie, Eleftheria Lefkou, Patrick Van Dreden, et al.. (2014). Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability. BMC Cancer. 14(1). 991–991. 43 indexed citations

Elalamy, Ismaı̈l, et al.. (2013). The usefulness of platelet function evaluation in clinical practice. Annales de biologie clinique. 71(S1). 47–57. 3 indexed citations

Dreden, Patrick Van, Emmanuel Marret, Françis Bonnet, et al.. (2013). Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinoma. Thrombosis Research. 132(5). 584–591. 17 indexed citations

Gerotziafas, Grigoris, Patrick Van Dreden, François Lionnet, et al.. (2012). The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thrombosis and Haemostasis. 107(6). 1044–1052. 56 indexed citations

Robert, Françoise, et al.. (2012). Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: Confirmation in a prospective study. Platelets. 24(6). 441–447. 29 indexed citations

Chakroun, Tahar, et al.. (2011). The Cyclooxygenase-1 C50T Polymorphism Is Not Associated with Aspirin Responsiveness Status in Stable Coronary Artery Disease in Tunisian Patients. Genetic Testing and Molecular Biomarkers. 15(7-8). 513–516. 8 indexed citations

Gerotziafas, Grigoris, Elisabeth Mbemba, Patrick Van Dreden, et al.. (2011). Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7. Thrombosis Research. 129(6). 779–786. 35 indexed citations

Mirshahi, Pezhman, Anne‐Marie Faussat, Jeannette Soria, et al.. (2010). Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Letters. 295(2). 242–251. 26 indexed citations

10.

Addad, Faouzi, Tahar Chakroun, Ismaı̈l Elalamy, et al.. (2010). Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetes. International Journal of Hematology. 92(2). 296–301. 28 indexed citations

11.

Gerotziafas, Grigoris, Charlotte Dupont, Alex C. Spyropoulos, et al.. (2009). Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin. Thrombosis and Haemostasis. 102(7). 42–48. 14 indexed citations

12.

Petropoulou, Anna D., Grigoris Gerotziafas, M Samama, et al.. (2007). In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide. Thrombosis Research. 121(4). 493–497. 16 indexed citations

13.

Gerotziafas, Grigoris, Chryssoula Papageorgiou, Mohamed Hatmi, Meyer‐Michel Samama, & Ismaı̈l Elalamy. (2007). Clinical Studies with Anticoagulants to Improve Survival in Cancer Patients. Pathophysiology of Haemostasis and Thrombosis. 36(3-4). 204–211. 44 indexed citations

14.

Werts, Catherine, et al.. (2002). TNF‐α, inefficient by itself, potentiates IL‐1β‐induced PGHS‐2 expression in human pulmonary microvascular endothelial cells: requirement of NF‐κB and p38 MAPK pathways. British Journal of Pharmacology. 136(7). 1005–1014. 23 indexed citations

15.

Elalamy, Ismaı̈l, et al.. (2000). Inhibition by Extracellular cAMP of Phorbol 12-Myristate 13-Acetate-induced Prostaglandin H Synthase-2 Expression in Human Pulmonary Microvascular Endothelial Cells. Journal of Biological Chemistry. 275(18). 13662–13667. 16 indexed citations

16.

Elalamy, Ismaı̈l, Sharareh Emadi, B. Boris Vargaftig, & Mohamed Hatmi. (1997). Signal transduction involved in the platelet adenylate cyclase sensitization associated with PGH₂/TxA₂ receptor desensitization. British Journal of Haematology. 99(1). 190–196. 2 indexed citations

17.

Emadi, Sharareh, Ismaı̈l Elalamy, B. Boris Vargaftig, & Mohamed Hatmi. (1996). Reversible inhibition by protamine of human synovial and rabbit platelet secretory phospholipase A2. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1300(3). 226–232. 5 indexed citations

18.

Faili, Ahmad, Sharareh Emadi, B.B. Vargaftig, & Mohamed Hatmi. (1994). Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation. British Journal of Haematology. 88(1). 149–155. 12 indexed citations

19.

Faili, Ahmad, Jacques Randon, B. Boris Vargaftig, & Mohamed Hatmi. (1993). Reduction by arachidonic acid of prostaglandin i2-induced cyclic amp formation. Biochemical Pharmacology. 45(9). 1815–1820. 5 indexed citations

20.

Hatmi, Mohamed, Jacques Randon, Ahmad Faili, & B. Boris Vargaftig. (1993). Carrageenan‐induced activation of human platelets is dependent on the phospholipase C Pathway. British Journal of Haematology. 83(2). 270–275. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact